Please use this identifier to cite or link to this item:
Title: Microbial metabolic engineering for the production of isoprenoids in escherichia coli
Authors: Ji, Lin
Keywords: DRNTU::Engineering::Bioengineering
Issue Date: 2013
Abstract: Isoprenoids, consisting of more than 50,000 compounds, have many functions in plants, animals, and microorganisms. Many isoprenoids are used for the treatment of human diseases, such as malaria and cancers. Microbial metabolic engineering has been developed recently as a new approach to increase the production of isoprenoids. This method is easier and less expensive than chemical synthesis, and produces more isoprenoids than plant extraction method. All isoprenoids are synthesized from IPP and DMAPP through the mevalonate pathway or nonmevalonate pathway. This review focuses on the metabolic engineering of these two isoprenoid synthesis pathways for the production of functional isoprenoids in Escherichia coli. Despite some successes, the quantity of isoprenoids currently produced still cannot meet the demands. Thus, more efforts in developing new methods for further improving isoprenoid production are required.
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Theses

Files in This Item:
File Description SizeFormat 
  Restricted Access
769.13 kBAdobe PDFView/Open

Page view(s) 5

checked on Sep 28, 2020

Download(s) 5

checked on Sep 28, 2020

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.